Healthcare provider profile · identity verified

Brittany Ackley, MD

Allopathic & Osteopathic Physicians|Family Medicine · TEXARKANA, TX · NPI 1295155844

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Brittany Ackley, MD received $102.59 in general payments during 2025 across 1 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$102.59

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$102.59	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$102.59	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$102.59	1	2025
Source payment records 2025-10-01 · Lilly USA, LLC · $102.59 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	56	14
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	104	22
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	48	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	647	85
Atorvastatin Calcium	Atorvastatin Calcium	505	142
Amlodipine Besylate	Amlodipine Besylate	465	112
Rosuvastatin Calcium	Rosuvastatin Calcium	451	106
Pantoprazole Sodium	Pantoprazole Sodium	335	86
Gabapentin	Gabapentin	324	88
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	321	86
Losartan Potassium	Losartan Potassium	312	77
Levothyroxine Sodium	Levothyroxine Sodium	311	72
Albuterol Sulfate Hfa	Albuterol Sulfate	289	82
Potassium Chloride	Potassium Chloride	280	77
Lisinopril	Lisinopril	265	70
Furosemide	Furosemide	221	64
Metformin Hcl	Metformin Hcl	207	60
Fluticasone Propionate	Fluticasone Propionate	201	79
Duloxetine Hcl	Duloxetine Hcl	191	33
Hydrochlorothiazide	Hydrochlorothiazide	188	52
Acetaminophen-Codeine	Acetaminophen With Codeine	186	36
Ozempic	Semaglutide	182	41
Omeprazole	Omeprazole	180	49
Montelukast Sodium	Montelukast Sodium	179	44
Trazodone Hcl	Trazodone Hcl	179	46
Escitalopram Oxalate	Escitalopram Oxalate	166	36
Tizanidine Hcl	Tizanidine Hcl	162	42
Metoprolol Succinate	Metoprolol Succinate	158	43
Tramadol Hcl	Tramadol Hcl	155	35
Clonazepam	Clonazepam	153	18
Meloxicam	Meloxicam	147	44
Carvedilol	Carvedilol	135	32
Pregabalin	Pregabalin	131	25
Pravastatin Sodium	Pravastatin Sodium	122	27
Eliquis	Apixaban	111	23
Spironolactone	Spironolactone	110	31
Alprazolam	Alprazolam	109	16
Mounjaro	Tirzepatide	104	22
Ondansetron Hcl	Ondansetron Hcl	104	32
Sertraline Hcl	Sertraline Hcl	103	26
Fluoxetine Hcl	Fluoxetine Hcl	94	23
Glipizide Er	Glipizide	92	23
Metoprolol Tartrate	Metoprolol Tartrate	92	27
Clopidogrel	Clopidogrel Bisulfate	85	27
Ondansetron Odt	Ondansetron	82	27
Triamcinolone Acetonide	Triamcinolone Acetonide	81	36
Citalopram Hbr	Citalopram Hydrobromide	80	26
Esomeprazole Magnesium	Esomeprazole Magnesium	77	22
Buspirone Hcl	Buspirone Hcl	74	19
Lorazepam	Lorazepam	74	13
Prednisone	Prednisone	74	57
Famotidine	Famotidine	73	19
Glimepiride	Glimepiride	71	17
Fluconazole	Fluconazole	70	32
Bupropion Xl	Bupropion Hcl	65	13
Diclofenac Sodium	Diclofenac Sodium	64	12
Venlafaxine Hcl Er	Venlafaxine Hcl	63	11
Alendronate Sodium	Alendronate Sodium	61	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Jardiance	Empagliflozin	56	14
Tamsulosin Hcl	Tamsulosin Hcl	56	20
Allopurinol	Allopurinol	55	19
Clonidine Hcl	Clonidine Hcl	55	13
Hydroxyzine Hcl	Hydroxyzine Hcl	54	20
Mirtazapine	Mirtazapine	53	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	16
Quetiapine Fumarate	Quetiapine Fumarate	52	14
Ibuprofen	Ibuprofen	50	12
Linzess	Linaclotide	50	22
Simvastatin	Simvastatin	49	15
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	44
Temazepam	Temazepam	48	11
Trulicity	Dulaglutide	48	11
Celecoxib	Celecoxib	47	18
Symbicort	Budesonide/Formoterol Fumarate	47	16
Ventolin Hfa	Albuterol Sulfate	45	20
Amitriptyline Hcl	Amitriptyline Hcl	44	11
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	42	12
Chlorthalidone	Chlorthalidone	41	suppressed
Promethazine Hcl	Promethazine Hcl	41	11
Azithromycin	Azithromycin	40	33
Benazepril Hcl	Benazepril Hcl	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	12
Tresiba Flextouch U-100	Insulin Degludec	39	suppressed
Glipizide	Glipizide	38	11
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	11
Atenolol	Atenolol	35	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Topiramate	Topiramate	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Bumetanide	Bumetanide	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	14
Methocarbamol	Methocarbamol	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Finasteride	Finasteride	28	suppressed
Ketoconazole	Ketoconazole	28	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Diazepam	Diazepam	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Ramipril	Ramipril	23	suppressed
Rybelsus	Semaglutide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	22	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Torsemide	Torsemide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Baclofen	Baclofen	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Nitroglycerin	Nitroglycerin	20	13
Calcitriol	Calcitriol	19	suppressed
Diclofenac Potassium	Diclofenac Potassium	19	suppressed
Cephalexin	Cephalexin	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Verapamil Er	Verapamil Hcl	18	suppressed
Anastrozole	Anastrozole	17	suppressed
Belsomra	Suvorexant	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Trintellix	Vortioxetine Hydrobromide	17	suppressed
Levofloxacin	Levofloxacin	16	14
Naproxen	Naproxen	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Nystatin	Nystatin	15	suppressed
Acetazolamide	Acetazolamide	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Primidone	Primidone	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$102.59 · 1 records	Lilly USA, LLC	ZEPBOUND	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error